Market Overview:
Single cell genome sequencing helps analyze DNA and RNA of individual cells within a mixture or tissue sample. This technique overcomes limitations of bulk sequencing as it provides insights into heterogeneity within tissues and cell populations. It helps understand gene expression patterns, clonal evolution, stem cell regulation and many other biological processes at single cell resolution level.
Market key trends:
Advances in microfluidics and high-throughput technologies is one of the key trends driving growth of the single cell genome sequencing market. Integration of microfluidics with sequencing has enabled analysis of thousands of single cells simultaneously. This has improved data generation capabilities and resolution for analyzing complex tissues and cell populations. By automating sample preparation and partitioning individual cells into nanoliter-sized reaction volumes, microfluidics based platforms have increased throughput and reduced costs of single cell sequencing. This has expanded the scope of application to a wide range of research areas.
Segment Analysis
Content: The Single Cell Genome Sequencing Market is dominated by single cell DNA sequencing sub-segment. This is because single cell DNA sequencing technologies are mature and widespread compared to other platforms like single cell RNA sequencing technologies. Single cell DNA sequencing allows analysis of genomic variations at single cell resolution which helps understand heterogeneity within cell populations as well as their evolution.
Key Takeaways
The global single cell genome sequencing market is expected to witness high growth, exhibiting CAGR of 14.% over the forecast period, due to increasing investment in personalized medicine and single cell genomics research.
Regional analysis: North America dominated the global market in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to strong government funding for genomics research and rising stem cell research activities in the US. Asia Pacific is anticipated to be the fastest growing market during the forecast period, owing to increasing healthcare expenditure and growing genomics industry in China and India.
Key players: Key players operating in the single cell genome sequencing market are Oxford Nanopore Technologies plc (U.K.), 10x Genomics (U.S), Fluidigm Corporation (U.S.), Bio-Rad Laboratories (U.S.), Novogene Corporation (China), Illumina Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), NanoString Technologies, Inc. (U.S.), QIAGEN N.V. (Germany), and BGI Genomics Co. Ltd. (China).
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it